Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 0.2 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
36 priced months, Jul 2023 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
61.7% now, 53.6% in Sep 2025 · highest 82.0%, lowest 51.1%
Companies held
25 now, 29 in Sep 2025 · largest single holding 9.8% of equity
How long new positions last: of the 19 companies this fund started holding between Aug 2023 and Jul 2025, 74% were still held a year later — it usually keeps what it buys. Across active funds the figure is about 50%, and a fund’s figure has stayed similar from year to year. A description of how the fund is run, not of its results. How this was tested →
How it trades: no clear lean toward recent winners or losers (score -0.10 over 10 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 20 shared58.2%
- EODWHFEdelweiss · 15 shared58.0%
- Mirae Asset Healthcare FundMirae Asset · 14 shared57.7%
- Axis NIFTY Healthcare ETFAxis · 13 shared56.3%
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 13 shared56.3%
- DSP Nifty Healthcare Index FundDSP · 13 shared56.3%
- DSP Nifty Healthcare ETFDSP · 13 shared56.3%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 13 shared56.3%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
- None this month.
Largest increases
Largest reductions
- 01 Artemis Medicare Services Limited-61.3% -57,314
- 02 IPCA Laboratories Limited-27.7% -4,604
- 03 Global Health Limited-15.2% -3,373
- 04 Gland Pharma Limited-21.8% -3,066
- 05 Glenmark Pharmaceuticals Limited-7.5% -894
- 06 Navin Fluorine International Limited-10.7% -716
- 07 Torrent Pharmaceuticals Limited-4.8% -630
- 08 Divi's Laboratories Limited-4.1% -418
- 09 Apollo Hospitals Enterprise Limited-3.0% -217
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 9.83% | 9.53 Cr | 52,436 | by Jul 2023 (36 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 9.30% | 9.01 Cr | 9,700 | by Jul 2023 (36 mo+) |
| Neuland Laboratories Limited | Healthcare | Small Cap | 6.30% | 6.10 Cr | 2,859 | Aug 2024 (23 mo) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 6.19% | 6.00 Cr | 12,500 | by Jul 2023 (36 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 5.90% | 5.72 Cr | 7,000 | by Jul 2023 (36 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 5.36% | 5.19 Cr | 31,050 | Jan 2025 (19 mo) |
| Navin Fluorine International Limited | Chemicals | Small Cap | 5.11% | 4.95 Cr | 6,000 | Aug 2024 (23 mo) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 5.10% | 4.94 Cr | 42,500 | May 2026 (5 mo) |
| Aster DM Quality Care Limited | Healthcare | Small Cap | 4.73% | 4.58 Cr | 65,750 | May 2026 (5 mo) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 3.86% | 3.74 Cr | 48,600 | Apr 2025 (16 mo) |
| Metropolis Healthcare Limited | Healthcare | Small Cap | 3.44% | 3.33 Cr | 61,500 | Aug 2023 (35 mo) |
| Gland Pharma Limited | Healthcare | Small Cap | 3.28% | 3.18 Cr | 10,977 | Jul 2025 (13 mo) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 3.19% | 3.09 Cr | 12,327 | Feb 2024 (29 mo) |
| Nephrocare Health Services Limited | Healthcare | Small Cap | 3.13% | 3.03 Cr | 46,000 | Sep 2026 (1 mo) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 3.07% | 2.98 Cr | 32,000 | Apr 2025 (16 mo) |
| Cohance Lifesciences Limited | Healthcare | Small Cap | 3.02% | 2.93 Cr | 65,950 | Jul 2026 (3 mo) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 2.67% | 2.59 Cr | 11,100 | Mar 2024 (28 mo) |
| Global Health Limited | Healthcare | Mid Cap | 2.66% | 2.58 Cr | 18,879 | Aug 2023 (35 mo) |
| Dr. Agarwal's Health Care Limited | Not classified | Small Cap | 2.52% | 2.44 Cr | 51,001 | Jan 2025 (19 mo) |
| Biocon Limited | Healthcare | Mid Cap | 2.43% | 2.35 Cr | 63,500 | May 2026 (5 mo) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 2.39% | 2.31 Cr | 12,000 | by Jul 2023 (36 mo+) |
| Onesource Specialty Pharma Limited | Healthcare | Small Cap | 2.36% | 2.28 Cr | 15,009 | Feb 2025 (18 mo) |
| Piramal Pharma Limited | Healthcare | Small Cap | 1.47% | 1.42 Cr | 69,000 | Sep 2026 (1 mo) |
| Syngene International Limited | Healthcare | Small Cap | 1.41% | 1.37 Cr | 37,400 | Aug 2026 (2 mo) |
| Artemis Medicare Services Limited | Not classified | Small Cap | 1.29% | 1.25 Cr | 36,215 | Sep 2023 (34 mo) |
Half of its current holdings have been held for 19 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Piramal Pharma Limited | Sep 2026 | ▲ New position | +69,000 |
| Artemis Medicare Services Limited | Sep 2026 | ▼ Reducing | -57,314 |
| Nephrocare Health Services Limited | Sep 2026 | ▲ New position | +46,000 |
| Syngene International Limited | Sep 2026 | ▲ Increasing | +12,400 |
| Max Healthcare Institute Limited | Sep 2026 | ▲ Increasing | +6,725 |
| Fortis Healthcare Limited | Sep 2026 | ▲ Increasing | +5,568 |
| Metropolis Healthcare Limited | Sep 2026 | ▲ Increasing | +5,371 |
| IPCA Laboratories Limited | Sep 2026 | ▼ Reducing | -4,604 |
| Global Health Limited | Sep 2026 | ▼ Reducing | -3,373 |
| Gland Pharma Limited | Sep 2026 | ▼ Reducing | -3,066 |
| Glenmark Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -894 |
| Navin Fluorine International Limited | Sep 2026 | ▼ Reducing | -716 |
| Torrent Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -630 |
| Divi's Laboratories Limited | Sep 2026 | ▼ Reducing | -418 |
| Apollo Hospitals Enterprise Limited | Sep 2026 | ▼ Reducing | -217 |
| Syngene International Limited | Aug 2026 | ▲ New position | +25,000 |
| Cohance Lifesciences Limited | Aug 2026 | ▲ Increasing | +11,450 |
| Dr. Agarwal's Health Care Limited | Aug 2026 | ▲ Increasing | +11,425 |
| Aster DM Quality Care Limited | Aug 2026 | ▲ Increasing | +10,250 |
| Metropolis Healthcare Limited | Aug 2026 | ▲ Increasing | +8,825 |
| Divi's Laboratories Limited | Aug 2026 | ▼ Reducing | -1,365 |
| Cohance Lifesciences Limited | Jul 2026 | ▲ New position | +54,500 |
| Anthem Biosciences Limited | Jul 2026 | ▼ Complete exit | -25,333 |
| Aster DM Quality Care Limited | Jul 2026 | ▲ Increasing | +18,000 |
| Max Healthcare Institute Limited | Jul 2026 | ▲ Increasing | +8,500 |
| Acutaas Chemicals Limited | Jul 2026 | ▼ Complete exit | -6,296 |
| Mankind Pharma Limited | Jul 2026 | ▲ Increasing | +3,750 |
| Divi's Laboratories Limited | Jul 2026 | ▲ Increasing | +1,400 |
| Zydus Lifesciences Limited | Jun 2026 | ▲ Increasing | +16,500 |
| Piramal Pharma Limited | May 2026 | ▼ Complete exit | -0.02 Cr |
| Biocon Limited | May 2026 | ▲ New position | +63,500 |
| Aster DM Quality Care Limited | May 2026 | ▲ New position | +37,500 |
| Zydus Lifesciences Limited | May 2026 | ▲ New position | +26,000 |
| Concord Biotech Limited | May 2026 | ▼ Complete exit | -20,531 |
| Cipla Limited | May 2026 | ▼ Complete exit | -19,567 |
| Vinati Organics Limited | May 2026 | ▼ Complete exit | -8,741 |
| Global Health Limited | May 2026 | ▲ Increasing | +7,300 |
| Onesource Specialty Pharma Limited | May 2026 | ▼ Reducing | -7,150 |
| Alkem Laboratories Limited | May 2026 | ▼ Complete exit | -5,008 |
| Divi's Laboratories Limited | May 2026 | ▲ Increasing | +3,925 |
| Navin Fluorine International Limited | May 2026 | ▲ Increasing | +2,600 |
| Abbott India Limited | May 2026 | ▼ Complete exit | -968 |
| Neuland Laboratories Limited | May 2026 | ▲ Increasing | +274 |
| Aurobindo Pharma Limited | May 2026 | ▼ Reducing | -251 |
| Cipla Limited | Jan 2026 | ▼ Reducing | -11,651 |
| Piramal Pharma Limited | Jan 2026 | ▲ Increasing | +10,010 |
| Acutaas Chemicals Limited | Jan 2026 | ▼ Reducing | -2,006 |
| Fortis Healthcare Limited | Jan 2026 | ▲ Increasing | +930 |
| Onesource Specialty Pharma Limited | Jan 2026 | ▲ Increasing | +833 |
| Neuland Laboratories Limited | Jan 2026 | ▲ Increasing | +117 |
| Piramal Pharma Limited | Dec 2025 | ▲ Increasing | +9,966 |
| Concord Biotech Limited | Dec 2025 | ▲ Increasing | +2,787 |
| Linde India Limited | Dec 2025 | ▼ Complete exit | -1,559 |
| Sun Pharmaceutical Industries Limited | Dec 2025 | ▼ Reducing | -1,415 |
| Navin Fluorine International Limited | Dec 2025 | ▼ Reducing | -680 |
| Alkem Laboratories Limited | Dec 2025 | ▼ Reducing | -147 |
| Onesource Specialty Pharma Limited | Dec 2025 | ▲ Increasing | +123 |
| Neuland Laboratories Limited | Dec 2025 | ▲ Increasing | +54 |
| Artemis Medicare Services Limited | Nov 2025 | ▼ Reducing | -15,303 |
| Concord Biotech Limited | Nov 2025 | ▲ Increasing | +4,346 |
| IPCA Laboratories Limited | Nov 2025 | ▼ Reducing | -1,707 |
| Acutaas Chemicals Limited | Nov 2025 | ▼ Reducing | -1,409 |
| Alkem Laboratories Limited | Nov 2025 | ▼ Reducing | -1,057 |
| Onesource Specialty Pharma Limited | Nov 2025 | ▲ Increasing | +743 |
| Dr. Agarwal's Health Care Limited | Oct 2025 | ▼ Reducing | -10,108 |
| J.B. Chemicals & Pharmaceuticals Lt | Oct 2025 | ▼ Complete exit | -9,736 |
| Onesource Specialty Pharma Limited | Oct 2025 | ▲ Increasing | +4,885 |
| Anthem Biosciences Limited | Oct 2025 | ▲ Increasing | +4,466 |
| Gland Pharma Limited | Jul 2025 | ▲ New position | +13,351 |
| Anthem Biosciences Limited | Jul 2025 | ▲ New position | +12,536 |
| Syngene International Limited | Jul 2025 | ▼ Reducing | -11,112 |
| Dr. Agarwal's Health Care Limited | Jul 2025 | ▼ Reducing | -10,625 |
| Vinati Organics Limited | Jul 2025 | ▼ Reducing | -6,663 |
| J.B. Chemicals & Pharmaceuticals Lt | Jul 2025 | ▼ Reducing | -5,016 |
| Apollo Hospitals Enterprise Limited | Jul 2025 | ▲ Increasing | +2,459 |
| Zydus Lifesciences Limited | Jul 2025 | ▼ Reducing | -2,182 |
| Neuland Laboratories Limited | Jul 2025 | ▼ Reducing | -597 |
| Linde India Limited | Jul 2025 | ▼ Reducing | -199 |
| Glenmark Pharmaceuticals Limited | Jul 2025 | ▼ Reducing | -156 |
| Acutaas Chemicals Limited | Jun 2025 | ▲ New position | +9,711 |
| Fortis Healthcare Limited | Jun 2025 | ▼ Reducing | -5,612 |
| Navin Fluorine International Limited | Jun 2025 | ▼ Reducing | -1,840 |
| Sanofi Consumer Healthcare India Limited | Jun 2025 | ▼ Complete exit | -1,740 |
| Piramal Pharma Limited | May 2025 | ▼ Reducing | -38,176 |
| Artemis Medicare Services Limited | May 2025 | ▼ Reducing | -28,276 |
| Laurus Labs Limited | May 2025 | ▼ Complete exit | -25,578 |
| Fortis Healthcare Limited | May 2025 | ▲ Increasing | +21,555 |
| Sun Pharmaceutical Industries Limited | May 2025 | ▲ Increasing | +7,513 |
| Onesource Specialty Pharma Limited | May 2025 | ▼ Reducing | -6,964 |
| Cipla Limited | May 2025 | ▲ Increasing | +3,947 |
| Linde India Limited | May 2025 | ▲ New position | +1,758 |
| Global Health Limited | May 2025 | ▼ Reducing | -1,742 |
| Mankind Pharma Limited | May 2025 | ▼ Reducing | -1,729 |
| Neuland Laboratories Limited | May 2025 | ▲ Increasing | +827 |
| Sanofi Consumer Healthcare India Limited | May 2025 | ▲ Increasing | +45 |
| Fortis Healthcare Limited | Apr 2025 | ▲ New position | +26,159 |
| Max Healthcare Institute Limited | Apr 2025 | ▲ New position | +16,775 |
| Artemis Medicare Services Limited | Apr 2025 | ▼ Reducing | -16,688 |
| Glenmark Pharmaceuticals Limited | Apr 2025 | ▼ Reducing | -12,464 |
| Zydus Lifesciences Limited | Apr 2025 | ▼ Reducing | -10,902 |
Changes compare consecutive month-end disclosures for this portfolio only.